US Stock MarketDetailed Quotes

PDS Biotechnology (PDSB)

Watchlist
  • 0.9005
  • -0.0276-2.97%
Close Apr 24 16:00 ET
  • 0.9006
  • +0.0001+0.01%
Post 19:48 ET
50.26MMarket Cap-1.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PDS Biotechnology (PDSB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.15%31.54M
-9.32%6.67M
-20.03%8.14M
-12.22%7.62M
-9.82%9.11M
-15.62%36.32M
-29.27%7.36M
-3.24%10.18M
-31.60%8.68M
7.17%10.1M
Selling and administrative expenses
-9.00%12.52M
-19.84%2.27M
5.60%3.56M
-17.95%3.41M
-3.50%3.27M
-9.99%13.76M
-3.75%2.83M
-17.10%3.37M
-11.40%4.16M
-5.18%3.39M
-General and administrative expense
-9.00%12.52M
-19.84%2.27M
5.60%3.56M
-17.95%3.41M
-3.50%3.27M
-9.99%13.76M
-3.75%2.83M
-17.10%3.37M
-11.40%4.16M
-5.18%3.39M
Research and development costs
-15.69%19.03M
-2.74%4.41M
-32.74%4.58M
-6.95%4.21M
-13.02%5.83M
-18.72%22.57M
-39.33%4.53M
5.51%6.8M
-43.44%4.53M
14.72%6.7M
Operating profit
13.15%-31.54M
9.32%-6.67M
20.03%-8.14M
12.22%-7.62M
9.82%-9.11M
15.62%-36.32M
29.27%-7.36M
3.24%-10.18M
31.60%-8.68M
-7.17%-10.1M
Net non-operating interest income expense
-90.95%-4.12M
-50.09%-888.21K
-58.64%-869.27K
-253.16%-1.81M
-9.33%-553.03K
-65.65%-2.16M
-20.46%-591.78K
-66.31%-547.96K
-109.51%-512.76K
-112.99%-505.85K
Non-operating interest income
-51.60%1.22M
-55.42%224.66K
-57.84%281.11K
-50.59%333.62K
-43.51%377.85K
-13.37%2.51M
-26.27%503.94K
-9.82%666.77K
-10.05%675.21K
-8.29%668.9K
Non-operating interest expense
14.24%5.34M
1.56%1.11M
-5.30%1.15M
80.52%2.14M
-20.76%930.88K
11.11%4.67M
-6.73%1.1M
13.64%1.21M
19.35%1.19M
21.50%1.17M
Other net income (expense)
Income before tax
7.31%-35.67M
4.90%-7.56M
16.01%-9.01M
-2.58%-9.43M
8.91%-9.66M
13.23%-38.48M
27.03%-7.95M
1.13%-10.73M
28.93%-9.2M
-9.77%-10.6M
Income tax
-34.59%-1.17M
0
0
0
-1.17M
38.18%-869.17K
0
0
38.18%-869.17K
0
Net income
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
Net income continuous Operations
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
Minority interest income
Net income attributable to the parent company
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
Basic earnings per share
28.16%-0.74
33.33%-0.14
34.48%-0.19
8.70%-0.21
30.00%-0.21
25.90%-1.03
40.00%-0.21
17.14%-0.29
37.84%-0.23
6.25%-0.3
Diluted earnings per share
28.16%-0.74
33.33%-0.14
34.48%-0.19
8.70%-0.21
30.00%-0.21
25.90%-1.03
40.00%-0.21
17.14%-0.29
37.84%-0.23
6.25%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.15%31.54M-9.32%6.67M-20.03%8.14M-12.22%7.62M-9.82%9.11M-15.62%36.32M-29.27%7.36M-3.24%10.18M-31.60%8.68M7.17%10.1M
Selling and administrative expenses -9.00%12.52M-19.84%2.27M5.60%3.56M-17.95%3.41M-3.50%3.27M-9.99%13.76M-3.75%2.83M-17.10%3.37M-11.40%4.16M-5.18%3.39M
-General and administrative expense -9.00%12.52M-19.84%2.27M5.60%3.56M-17.95%3.41M-3.50%3.27M-9.99%13.76M-3.75%2.83M-17.10%3.37M-11.40%4.16M-5.18%3.39M
Research and development costs -15.69%19.03M-2.74%4.41M-32.74%4.58M-6.95%4.21M-13.02%5.83M-18.72%22.57M-39.33%4.53M5.51%6.8M-43.44%4.53M14.72%6.7M
Operating profit 13.15%-31.54M9.32%-6.67M20.03%-8.14M12.22%-7.62M9.82%-9.11M15.62%-36.32M29.27%-7.36M3.24%-10.18M31.60%-8.68M-7.17%-10.1M
Net non-operating interest income expense -90.95%-4.12M-50.09%-888.21K-58.64%-869.27K-253.16%-1.81M-9.33%-553.03K-65.65%-2.16M-20.46%-591.78K-66.31%-547.96K-109.51%-512.76K-112.99%-505.85K
Non-operating interest income -51.60%1.22M-55.42%224.66K-57.84%281.11K-50.59%333.62K-43.51%377.85K-13.37%2.51M-26.27%503.94K-9.82%666.77K-10.05%675.21K-8.29%668.9K
Non-operating interest expense 14.24%5.34M1.56%1.11M-5.30%1.15M80.52%2.14M-20.76%930.88K11.11%4.67M-6.73%1.1M13.64%1.21M19.35%1.19M21.50%1.17M
Other net income (expense)
Income before tax 7.31%-35.67M4.90%-7.56M16.01%-9.01M-2.58%-9.43M8.91%-9.66M13.23%-38.48M27.03%-7.95M1.13%-10.73M28.93%-9.2M-9.77%-10.6M
Income tax -34.59%-1.17M000-1.17M38.18%-869.17K0038.18%-869.17K0
Net income 8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M
Net income continuous Operations 8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M
Minority interest income
Net income attributable to the parent company 8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M
Basic earnings per share 28.16%-0.7433.33%-0.1434.48%-0.198.70%-0.2130.00%-0.2125.90%-1.0340.00%-0.2117.14%-0.2937.84%-0.236.25%-0.3
Diluted earnings per share 28.16%-0.7433.33%-0.1434.48%-0.198.70%-0.2130.00%-0.2125.90%-1.0340.00%-0.2117.14%-0.2937.84%-0.236.25%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -